In the latest trading session,, 0.52 million Zura Bio Ltd (NASDAQ:ZURA) shares changed hands as the company’s beta touched 0.17. With the company’s most recent per share price at $1.12 changed hands at -$0.01 or -0.44% at last look, the market valuation stands at $76.92M. ZURA’s current price is a discount, trading about -466.96% off its 52-week high of $6.35. The share price had its 52-week low at $0.97, which suggests the last value was 13.39% up since then. When we look at Zura Bio Ltd’s average trading volume, we note the 10-day average is 0.41 million shares, with the 3-month average coming to 370.92K.
Analysts gave the Zura Bio Ltd (ZURA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.29. If we narrow down to specifics, the data shows that 0 out of 11 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 2 recommended ZURA as a Hold, 8 felt it is a Buy and 0 rated the stock as Underweight. Zura Bio Ltd’s EPS for the current quarter is expected to be 0.
Zura Bio Ltd (NASDAQ:ZURA) trade information
Instantly ZURA was in red as seen in intraday trades today. With action -3.85%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -55.00%, with the 5-day performance at -3.85% in the red. However, in the 30-day time frame, Zura Bio Ltd (NASDAQ:ZURA) is -7.79% down. Looking at the short shares, we see there were 5.31 million shares sold at short interest cover period of 21.89 days.
The consensus price target for the stock as assigned by Wall Street analysts is 9, meaning bulls need an upside of 87.56% from its recent market value. According to analyst projections, ZURA’s forecast low is 3 with 15 as the target high. To hit the forecast high, the stock’s price needs a -1239.29% plunge from its current level, while the stock would need to soar -167.86% for it to hit the projected low.
Zura Bio Ltd (ZURA) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%. The 2025 estimates are for Zura Bio Ltd earnings to decrease by -12.38%, but the outlook for the next 5-year period is at -15.63% per year.
Zura Bio Ltd (NASDAQ:ZURA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 27.51% of Zura Bio Ltd shares while 59.96% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 82.71%. There are 59.96% institutions holding the Zura Bio Ltd stock share, with VR ADVISER, LLC the top institutional holder. As of 2024-06-30, the company held 8.0365% of the shares, roughly 6.02 million ZURA shares worth $21.08 million.
SUVRETTA CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 6.4858% or 4.86 million shares worth $17.01 million as of 2024-06-30.
Among Mutual Funds, the top two as of Feb 28, 2025 were iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.14 shares estimated at $1.29 million under it, the former controlled 1.67% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.73% of the shares, roughly 500.32 shares worth around $0.57 million.
